Attached files
file | filename |
---|---|
EX-99.2 - PRESS RELEASE - SANUWAVE Health, Inc. | snwv_ex992.htm |
EX-99.1 - TRANSCRIPT OF THE MARCH 31, 2020, SANUWAVE HEALTH, INC. CONFERENCE CALL - SANUWAVE Health, Inc. | snwv_ex991.htm |
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 31,
2020
SANUWAVE Health, Inc.
(Exact Name of Registrant as Specified in Charter)
Nevada
|
|
000-52985
|
|
20-1176000
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
3360 Martin Farm Road, Suite 100
Suwanee, Georgia 30024
(Address of Principal Executive Offices, and Zip Code)
(770) 419-7525
Registrant’s Telephone Number, Including Area
Code
(Former Name or Former Address, if Changed Since Last
Report)
Check
the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[_] Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
[_] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
Common
Stock, par value $0.001
|
SNWV
|
OTCQB
|
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR
§240.12b-2 of this
chapter).
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02
Results of Operations and Financial Condition.
On March 31, 2020, SANUWAVE Health, Inc., a Nevada Corporation (the
“Company”), announced its financial results for the
full fiscal year ended December 31, 2019 and provided a business
update via conference call. A copy of the transcript of such call
is furnished as Exhibit 99.1 to this Form 8-K. A copy of the
related press release is furnished as Exhibit 99.2 to this Form
8-K.
The information in this Item 2.02 of this Current Report on Form
8-K and the exhibits attached hereto shall not be deemed to be
“filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, and shall not be deemed
incorporated by reference in any filing under the Securities Act of
1933, as amended, except as shall be expressly set forth by
specific reference in such filing.
Item
9.01
Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No.
Description
Transcript
of the March 31, 2020, SANUWAVE Health, Inc. conference call to
discuss the full fiscal year ended December 31, 2019 financial
results and provide a business update.
Press
release, dated March 31, 2020, issued by SANUWAVE Health, Inc.,
titled “SANUWAVE Health reports full year 2019 financial
results; COVID-19 related business update.”
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
SANUWAVE
HEALTH, INC.
|
|
|
|
|
|
|
Dated:
April 3, 2020
|
By:
|
/s/ Lisa E. Sundstrom
|
|
|
Name:
|
Lisa E.
Sundstrom
|
|
|
Title:
|
Chief
Financial Officer
|
|